Drostanolone Enanthate 200mg
Drostanolone Enanthate or Masteron is probably one of the most interesting steroids used by athletes. It is primarily designed for the treatment of breast cancer patients to inhibit estrogen production. Estrogen is the hormone secreted by females that gives them their distinct gender characteristics. Maseril, the trademark of Drostanolone Enanthate is used in breast cancer therapy and is combined with SERM (Selective Estrogen Receptor Modulator). There was a decrease in estrogen levels among women who had gone through the treatment using this hormone. Masteron had become a favorite steroid among athletes and competitive bodybuilders. It is a very popular anabolic steroid. Masteron is a derivative of dihydrotestosterone or DHT, which restrains the conversion to estrogen through aromatization. It could be that its ability to inhibit estrogen from interacting with the aromatase enzyme or it blocks the receptor that binds the estrogen that causes these phenomena. Whatever the reason, because of its anti-estrogenic properties it blocks the conversion of free testosterones to estrogen through the aromatization. This makes Masteron a common inclusion in a high anabolic cycle. Since compounds used in cycles to achieve mass gain and strength have very potent testosterone content, Masteron is used to prevent the estrogenic side effects to take place.
200mg/ml Drostanolone enanthate (10ml VIAL)
The side effects include bloating or water retention and gynecomastia. While some think that there is low
aromatization with Masteron it still has a significant androgenic side-effects that one should expect when using
this steroid. This may include bouts of oily skin, acne, and body/facial hair growth. Anabolic/androgenic steroids
may also aggravate male pattern hair loss. Anabolic/androgenic steroids can have deleterious effects on serum
cholesterol. This includes a tendency to reduce HDL (good) cholesterol values and increase LDL (bad) cholesterol
values, which may shift the HDL to LDL balance in a direction that causes greater risk of arteriosclerosis. It could
shut down the production of testosterone, so users should be careful to use this in post cycle therapy because it
could actually slowdown the recovery.
Drostanolonum enanthate is administrated by the intramuscular injection. It must not be given intravenously.
Intramuscular injections should be given deep in the gluteal muscle.
Males: 200-400 mg per week, given 2-3 times a week.
Females: for breast cancer treatment 200-300 mg per week, given 2-3 times a week. For physique or performance
enhancing purposes 50-75 mg per week, given 2-3 times a week